InsidersTradesSigma
Track the 威尔药业 share price and the full insider trade history of the company, a listed equity based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 威尔药业 has logged 3 reports. Market capitalisation: €3.1bn. The latest transaction was filed on 24 March 2023 (Sale). Among the most active insiders: 王福秋. The full history is free.
3
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€819,071
3 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,873 of 29,063 companies
57.9
score / 100
Value61
Quality55
FCF yld5.9%
Earn yld4.8%
EV/EBITDA11.8x
ROE8.4%
Gross mgn28%
Net mgn11%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 March 2023
关于 威尔药业
威尔药业是一家在医疗保健和制药领域运营的公司，在上海证券交易所上市。它专注于创新医药产品的开发和营销。